Transamerica Financial Advisors LLC purchased a new position in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) during the second quarter, Holdings Channel.com reports. The fund purchased 16,868 shares of the company’s stock, valued at approximately $2,172,000.
Several other hedge funds have also recently modified their holdings of the stock. Frazier Financial Advisors LLC purchased a new position in shares of Merck KGaA in the 2nd quarter valued at approximately $25,000. Rakuten Securities Inc. purchased a new stake in Merck KGaA during the 2nd quarter worth approximately $27,000. Solstein Capital LLC acquired a new position in Merck KGaA during the 2nd quarter valued at approximately $33,000. Delos Wealth Advisors LLC acquired a new position in Merck KGaA during the 2nd quarter valued at approximately $33,000. Finally, Burk Holdings LLC purchased a new position in shares of Merck KGaA in the second quarter worth $39,000. Institutional investors and hedge funds own 0.10% of the company’s stock.
Merck KGaA Trading Up 0.4%
OTCMKTS:MKGAF opened at $164.58 on Thursday. Merck KGaA has a 12 month low of $116.68 and a 12 month high of $175.56. The firm has a fifty day simple moving average of $163.19 and a 200-day simple moving average of $148.83. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27. The company has a market capitalization of $21.27 billion, a P/E ratio of 25.13 and a beta of 0.96.
About Merck KGaA
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Further Reading
- Five stocks we like better than Merck KGaA
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
